Search

Search Constraints

You searched for: Author/Creator Baker, Jason V

Search Results

1. Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3). (February 2022)

2. Factor Xa Inhibition Reduces Coagulation Activity but Not Inflammation Among People With HIV: A Randomized Clinical Trial. (1st February 2020)

3. Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START study. Issue 6 (27th June 2019)

4. Inflammation Associates With Impaired Small Arterial Elasticity Early in HIV Disease. (19th May 2018)

5. Investigation of Causal Effects of Protein Biomarkers on Cardiovascular Disease in Persons With HIV. (29th December 2022)

6. Role of Inflammatory Biomarkers in the Prevalence and Incidence of Hypertension Among HIV-Positive Participants in the START Trial. (6th September 2019)

7. Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) Study. (13th December 2017)

8. The Effects of Recombinant Human Lactoferrin on Immune Activation and the Intestinal Microbiome Among Persons Living with Human Immunodeficiency Virus and Receiving Antiretroviral Therapy. (5th February 2019)

10. Vorapaxar for HIV-associated inflammation and coagulopathy (ADVICE): a randomised, double-blind, placebo-controlled trial. Issue 10 (October 2018)